FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Clears Pantheris for In-stent Restinosis

FDA clears an Avinger 510(k) for a new clinical indication for the Pantheris image-guided atherectomy system treating in-stent restenosis in the lowe...

Medical Devices

FDA Qualifies MED Institute MRI Safety Tool

FDA qualifies the MED Institutes medical device development tool for virtual MRI safety evaluations of patients with implanted medical devices.

Medical Devices

FDA Clears MIM Molecular Radiotherapy Software

FDA clears a MIM Software 510(k) for its MIM SurePlan MRT, a software package for molecular radiotherapy.

Federal Register

18 No-Longer-Marketed ANDAs Withdrawn

Federal Register notice: FDA withdraws approval of 18 ANDAs from multiple applicants after they notified the agency that the drugs were no longer mark...

Human Drugs

Disqualify 2 Minnesota Researchers: Public Citizen

Public Citizen says FDA should disqualify from conducting clinical trials two doctors at the Hennepin County Medical Center and the centers institutio...

Marketing

Fast Track for AstraZeneca Lokelma Indication

FDA grants fast track designation to AstraZenecas hyperkalemia drug Lokelma to reduce arrhythmia-related cardiovascular outcomes in patients on chroni...

Medical Devices

Changes for Electronic Submission Guidance

Cook Group recommends improvements to an FDA draft guidance on the electronic submission eSTAR template.

Medical Devices

Blackrock Neurotech Breakthrough Status for Brain Interface

FDA grants Blackrock Neurotech a breakthrough device designation for its MoveAgain Brain Computer Interface System that is intended to provide immobil...

Human Drugs

CytoDyn Resubmits Rolling BLA for HIV Therapy

CytoDyn begins resubmitting a rolling BLA for leronlimab, a CCR5 antagonist used in combination therapy with highly active antiretroviral therapy for ...

Human Drugs

MIDD Pilot Updated

FDA says it is asking the Model-Informed Drug Development meeting requests and packages to include a credibility framework.